Hormone therapy can be effective for receptor-positive breast cancer, but it only works for 55% of patients. Researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to a one-day estrogen challenge benefited from hormone therapy. The findings could help improve treatment decisions.
